Literature DB >> 25606299

A joint estimation detection of Glaucoma progression in 3D spectral domain optical coherence tomography optic nerve head images.

Akram Belghith1, Christopher Bowd1, Robert N Weinreb1, Linda M Zangwill1.   

Abstract

Glaucoma is an ocular disease characterized by distinctive changes in the optic nerve head (ONH) and visual field. Glaucoma can strike without symptoms and causes blindness if it remains without treatment. Therefore, early disease detection is important so that treatment can be initiated and blindness prevented. In this context, important advances in technology for non-invasive imaging of the eye have been made providing quantitative tools to measure structural changes in ONH topography, an essential element for glaucoma detection and monitoring. 3D spectral domain optical coherence tomography (SD-OCT), an optical imaging technique, has been commonly used to discriminate glaucomatous from healthy subjects. In this paper, we present a new framework for detection of glaucoma progression using 3D SD-OCT images. In contrast to previous works that the retinal nerve fiber layer (RNFL) thickness measurement provided by commercially available spectral-domain optical coherence tomograph, we consider the whole 3D volume for change detection. To integrate a priori knowledge and in particular the spatial voxel dependency in the change detection map, we propose the use of the Markov Random Field to handle a such dependency. To accommodate the presence of false positive detection, the estimated change detection map is then used to classify a 3D SDOCT image into the "non-progressing" and "progressing" glaucoma classes, based on a fuzzy logic classifier. We compared the diagnostic performance of the proposed framework to existing methods of progression detection.

Entities:  

Keywords:  Glaucoma; Markov field; change detection; fuzzy logic classifier

Year:  2014        PMID: 25606299      PMCID: PMC4297669          DOI: 10.1117/12.2041980

Source DB:  PubMed          Journal:  Proc SPIE Int Soc Opt Eng        ISSN: 0277-786X


  10 in total

1.  Spectral domain optical coherence tomography: ultra-high speed, ultra-high resolution ophthalmic imaging.

Authors:  Teresa C Chen; Barry Cense; Mark C Pierce; Nader Nassif; B Hyle Park; Seok H Yun; Brian R White; Brett E Bouma; Guillermo J Tearney; Johannes F de Boer
Journal:  Arch Ophthalmol       Date:  2005-12

2.  Effect of image quality on tissue thickness measurements obtained with spectral domain-optical coherence tomography.

Authors:  Madhusudhanan Balasubramanian; Christopher Bowd; Gianmarco Vizzeri; Robert N Weinreb; Linda M Zangwill
Journal:  Opt Express       Date:  2009-03-02       Impact factor: 3.894

Review 3.  Regulation of retinal and optic nerve blood flow.

Authors:  A Harris; T A Ciulla; H S Chung; B Martin
Journal:  Arch Ophthalmol       Date:  1998-11

4.  Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. The Rotterdam Study.

Authors:  I Dielemans; P T de Jong; R Stolk; J R Vingerling; D E Grobbee; A Hofman
Journal:  Ophthalmology       Date:  1996-08       Impact factor: 12.079

5.  Localized glaucomatous change detection within the proper orthogonal decomposition framework.

Authors:  Madhusudhanan Balasubramanian; David J Kriegman; Christopher Bowd; Michael Holst; Robert N Weinreb; Pamela A Sample; Linda M Zangwill
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-14       Impact factor: 4.799

6.  Comparison of retinal nerve fiber layer thickness measured by Cirrus HD and Stratus optical coherence tomography.

Authors:  Kyung Rim Sung; Dong Yoon Kim; Sung Bae Park; Michael S Kook
Journal:  Ophthalmology       Date:  2009-05-08       Impact factor: 12.079

7.  Machine learning classifiers for glaucoma diagnosis based on classification of retinal nerve fibre layer thickness parameters measured by Stratus OCT.

Authors:  Dimitrios Bizios; Anders Heijl; Jesper Leth Hougaard; Boel Bengtsson
Journal:  Acta Ophthalmol       Date:  2010-01-08       Impact factor: 3.761

Review 8.  Optical coherence tomography to detect and manage retinal disease and glaucoma.

Authors:  Glenn J Jaffe; Joseph Caprioli
Journal:  Am J Ophthalmol       Date:  2004-01       Impact factor: 5.258

9.  Sensitivity and specificity of time-domain versus spectral-domain optical coherence tomography in diagnosing early to moderate glaucoma.

Authors:  Robert T Chang; O'Rese J Knight; William J Feuer; Donald L Budenz
Journal:  Ophthalmology       Date:  2009-10-02       Impact factor: 12.079

10.  Spectral domain-optical coherence tomography to detect localized retinal nerve fiber layer defects in glaucomatous eyes.

Authors:  Gianmarco Vizzeri; Madhusudhanan Balasubramanian; Christopher Bowd; Robert N Weinreb; Felipe A Medeiros; Linda M Zangwill
Journal:  Opt Express       Date:  2009-03-02       Impact factor: 3.894

  10 in total
  4 in total

1.  Forecasting Retinal Nerve Fiber Layer Thickness from Multimodal Temporal Data Incorporating OCT Volumes.

Authors:  Suman Sedai; Bhavna Antony; Hiroshi Ishikawa; Gadi Wollstein; Joel S Schuman; Rahil Garnavi
Journal:  Ophthalmol Glaucoma       Date:  2019-11-08

2.  Learning from healthy and stable eyes: A new approach for detection of glaucomatous progression.

Authors:  Akram Belghith; Christopher Bowd; Felipe A Medeiros; Madhusudhanan Balasubramanian; Robert N Weinreb; Linda M Zangwill
Journal:  Artif Intell Med       Date:  2015-04-23       Impact factor: 5.326

3.  Profitability analysis of a femtosecond laser system for cataract surgery using a fuzzy logic approach.

Authors:  José Antonio Trigueros; David P Piñero; Mahmoud M Ismail
Journal:  Int J Ophthalmol       Date:  2016-07-18       Impact factor: 1.779

4.  Artificial Intelligence Algorithms to Diagnose Glaucoma and Detect Glaucoma Progression: Translation to Clinical Practice.

Authors:  Anna S Mursch-Edlmayr; Wai Siene Ng; Alberto Diniz-Filho; David C Sousa; Louis Arnold; Matthew B Schlenker; Karla Duenas-Angeles; Pearse A Keane; Jonathan G Crowston; Hari Jayaram
Journal:  Transl Vis Sci Technol       Date:  2020-10-15       Impact factor: 3.283

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.